Correction to: Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy

Arora, Supriya; Maltsev, Dmitrii S.; Sahoo, Niroj Kumar; Parameshwarappa, Deepika; Iovino, Claudio; Arora, Tarun; Kulikov, Alexei N.; Tatti, Filippo; Venkatesh, Ramesh; Reddy, Nikitha Gurram; Pulipaka, Ram Snehith; Singh, Sumit Randhir; Peiretti, Enrico; Chhablani, Jay

doi:10.1038/s41433-021-01837-y

Eye

2021

DOI: 10.1038/s41433-021-01837-y

|View full text |Cite

Correction to: Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy

Supriya Arora¹,

Dmitrii S. Maltsev

Niroj Kumar Sahoo

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study

Liu

et al. 2022

BMC Ophthalmol

View full text Add to dashboard Cite

Background To assess the efficacy of 577 nm subthreshold micropulse laser (SML) treatment for acute central serous chorioretinopathy (CSC). Methods This retrospective comparative case-series included 34 eyes of 34 patients with acute CSC who received either 577 nm SML treatment (SML group, n = 16 eyes) or were only monitored (observation group, n = 18 eyes). Acute CSC was defined as disease course < 3 months. Eyes with any history of treatment in the past were excluded. Data were collected over a period of 6 months. The best corrected visual acuity (BCVA), central macular thickness (CMT), and subfoveal choroidal thickness (SFCT) were observed. Results SML group showed significantly greater improvement in the BCVA (logMAR) compared to observation group at 1 month (0.20 ± 0.10 vs 0.30 ± 0.12, P < 0.01), 3 months (0.13 ± 0.06 vs 0.21 ± 0.06, P < 0.01) and 6 months (0.01 ± 0.06 vs 0.09 ± 0.66, P < 0.01). The CMT reduction was significantly greater in the SML group at 1 month (337.19 ± 62.96 µm vs 395.11 ± 91.30 µm, P < 0.05), 3 months (312.94 ± 49.50 µm vs 364.50 ± 70.30 µm, P < 0.05) and 6 months (291.38 ± 26.46 µm vs 348.56 ± 54.65 µm, P < 0.05). In the SML group, the SFCT did not show a significant decrease at 1 month (468.88 ± 42.19 µm, P > 0.05) but showed a significant reduction at 3 months (451.75 ± 39.36 µm, P < 0.05) and 6 months (450.50 ± 34.24 µm, P < 0.05) from baseline (489.94 ± 45.86 µm). In the observation group, there was no significant change in SFCF during follow-up. No adverse events occurred in the SML group. Conclusions Although some patients with acute CSC show spontaneous healing, timely intervention with 577 nm SML can shorten the disease course, improve visual acuity, and reduce the risk of chronic transformation without adverse events.

show abstract

577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study

Liu

et al. 2022

BMC Ophthalmol

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Correction to: Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy

Cited by 1 publication

References 0 publications

577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study

577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study

Contact Info

Product

Resources

About